Earlier this year, researchers at Children's Hospital of Philadelphia and Penn created a first-of-its-kind drug customized to a unique genetic mutation to save an infant named Baby KJ from dying of a rare liver disorder.
from Medical Xpress - latest medical and health news stories https://ift.tt/tOgkSzK
